BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $269,000 | -2.9% | 22,750 | +8.1% | 0.01% | +18.2% |
| Q2 2022 | $277,000 | -60.9% | 21,050 | -37.9% | 0.01% | -57.7% |
| Q1 2022 | $709,000 | -5.3% | 33,903 | -7.9% | 0.03% | -3.7% |
| Q4 2021 | $749,000 | -4.1% | 36,827 | +43.1% | 0.03% | -18.2% |
| Q3 2021 | $781,000 | +18.0% | 25,727 | +12.9% | 0.03% | +17.9% |
| Q2 2021 | $662,000 | -72.4% | 22,796 | -59.0% | 0.03% | -71.7% |
| Q1 2021 | $2,399,000 | -10.2% | 55,596 | -3.9% | 0.10% | -2.9% |
| Q4 2020 | $2,672,000 | +5.7% | 57,847 | -0.8% | 0.10% | -14.3% |
| Q3 2020 | $2,528,000 | +141.7% | 58,303 | +195.5% | 0.12% | +101.7% |
| Q2 2020 | $1,046,000 | – | 19,730 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |